Farallon Capital Management’s Cogent Biosciences COGT Stock Holding History

Farallon Capital Management’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$654K	Hold	17,000	–	–	﹤0.01%	105
2025 Q4	$604K	Hold	17,000	–	–	﹤0.01%	91
2025 Q3	$244K	Hold	17,000	–	–	﹤0.01%	113
2025 Q2	$122K	Hold	17,000	–	–	﹤0.01%	128
2025 Q1	$102K	Hold	17,000	–	–	﹤0.01%	136
2024 Q4	$133K	Hold	17,000	–	–	﹤0.01%	139
2024 Q3	$184K	Sell	17,000 -408,161	-96%	-$3.97M	﹤0.01%	145
2024 Q2	$3.58M	Sell	425,161 -36,839	-8%	-$279K	0.02%	96
2024 Q1	$3.1M	Buy	462,000 +445,000	+2,618%	+$2.75M	0.01%	108
2023 Q4	$100K	Hold	17,000	–	–	﹤0.01%	136
2023 Q3	$166K	Sell	17,000 -966,452	-98%	-$11.5M	﹤0.01%	133
2023 Q2	$11.6M	Hold	983,452	–	–	0.06%	88
2023 Q1	$10.6M	Buy	983,452 +898,313	+1,055%	+$11.5M	0.06%	97
2022 Q4	$984K	Sell	85,139 -160,000	-65%	-$1.98M	0.01%	173
2022 Q3	$3.66M	Sell	245,139 -754,861	-75%	-$10.3M	0.02%	191
2022 Q2	$9.02M	Buy	1,000,000 +150,000	+18%	+$1.02M	0.05%	142
2022 Q1	$6.37M	Buy	850,000 +250,000	+42%	+$1.74M	0.03%	173
2021 Q4	$5.15M	Hold	600,000	–	–	0.03%	180
2021 Q3	$5.05M	Hold	600,000	–	–	0.02%	182
2021 Q2	$4.87M	Hold	600,000	–	–	0.02%	185
2021 Q1	$5.27M	Hold	600,000	–	–	0.03%	181
2020 Q4	$6.74M	Buy	+600,000	New	+$6.59M	0.04%	114

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Farallon Capital Management's COGT Position: Q1 2026 in Review

Farallon Capital Management held its Cogent Biosciences (COGT) position steady in Q1 2026 at 17,000 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #105.

Farallon Capital Management first reported a position in COGT in Q4 2020 and has held it in 22 quarters since. The position peaked at $11.6M in Q2 2023. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Farallon Capital Management held 17,000 shares of Cogent Biosciences worth $654K as of Q1 2026.
Farallon Capital Management left its Cogent Biosciences share count unchanged in Q1 2026.
Cogent Biosciences made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #105 holding.
Farallon Capital Management first reported a position in Cogent Biosciences in Q4 2020 and has held it in 22 quarters since.
Farallon Capital Management's Cogent Biosciences position peaked at $11.6M in Q2 2023.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.